EUVIMEDEUVIMED entdecken
LeserbriefKohortenstudie

Real‐World Effectiveness, Safety and Drug Survival of Tildrakizumab in Adult Patients With Plaque Psoriasis: A 2‐Year Portuguese Multicenter Retrospective Cohort Study

Tiago Torres iD, Barbara Vieira Granja, Rita Guedes, Joana Antunes iD, Martim Luz, Maria João Cruz, Ana Brasileiro, Joana Rocha, João Alves, Luiz Leite, Joana Valério, Barbara Leal und 8 weitere

International Journal of Dermatology · 2025-12 · 64 (12) · 2373-2376

DOI: 10.1111/ijd.17977 ↗

Kurz gefasst

Leserbrief in der Zeitschrift International Journal of Dermatology, online erschienen am 17.07.2025. Verfasst von Tiago Torres und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Centro Académico Clínico ICBAS/Santo António, Porto, Portugal. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 5 Literaturangaben. Gefördert von: Almirall - Produtos Farmacêuticos, Lda. Rua do Central Park, Edificio 3, numero 6, 4B, 2795-242 Linda A Velha, Portugal, Almirall.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

IL‐23 inhibitordrug survivaleffectivenesspsoriasisreal‐world evidencetildrakizumab

Autor:innen und Institutionen

  • Department of Dermatology, Centro Académico Clínico ICBAS/Santo António, Porto, Portugal.
  • Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Porto, Portugal.
  • Department of Dermatology, ULS de São João, Porto, Portugal.
  • Department of Biomedicine, Faculty of Medicine of the University of Porto, Porto, Portugal.
  • Department of Dermatology, ULS de Gaia/Espinho, Gaia, Portugal.
  • Department of Dermatology, ULS de Santa Maria, Lisboa, Portugal.

ORCID-Profile: Tiago Torres, Joana Antunes, Gustavo Silva, Hugo Leme

Förderung

  • Almirall - Produtos Farmacêuticos, Lda. Rua do Central Park, Edificio 3, numero 6, 4B, 2795-242 Linda A Velha, Portugal
  • Almirall

Zitieren

APA

Torres, T., Vieira Granja, B., Guedes, R., Antunes, J., Luz, M., Cruz, M. J., Brasileiro, A., Rocha, J., Alves, J., Leite, L., Valério, J., Leal, B., Matos, J., Silva, G., Leme, H., Henrique, M., Varela, P., Mendes-Bastos, P., Magina, S., & Ferreira, P. (2025). Real‐World Effectiveness, Safety and Drug Survival of Tildrakizumab in Adult Patients With Plaque Psoriasis: A 2‐Year Portuguese Multicenter Retrospective Cohort Study. International Journal of Dermatology, 64(12), 2373-2376. https://doi.org/10.1111/ijd.17977

Vancouver

Torres T, Vieira Granja B, Guedes R, Antunes J, Luz M, Cruz MJ, et al. Real‐World Effectiveness, Safety and Drug Survival of Tildrakizumab in Adult Patients With Plaque Psoriasis: A 2‐Year Portuguese Multicenter Retrospective Cohort Study. International Journal of Dermatology. 2025;64(12):2373-2376. doi:10.1111/ijd.17977

BibTeX
@article{Torres2025,
  author = {Torres, Tiago and Vieira Granja, Barbara and Guedes, Rita and Antunes, Joana and Luz, Martim and Cruz, Maria João and Brasileiro, Ana and Rocha, Joana and Alves, João and Leite, Luiz and Valério, Joana and Leal, Barbara and Matos, Joana and Silva, Gustavo and Leme, Hugo and Henrique, Martinha and Varela, Paulo and Mendes-Bastos, Pedro and Magina, Sofia and Ferreira, Paulo},
  title = {Real‐World Effectiveness, Safety and Drug Survival of Tildrakizumab in Adult Patients With Plaque Psoriasis: A 2‐Year Portuguese Multicenter Retrospective Cohort Study},
  journal = {International Journal of Dermatology},
  year = {2025},
  volume = {64},
  number = {12},
  pages = {2373--2376},
  doi = {10.1111/ijd.17977}
}
Kostenlos starten →